ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

MYX Mycelx Technologies Corporation

61.00
0.00 (0.00%)
07 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Mycelx Technologies Corporation LSE:MYX London Ordinary Share COM SHS USD0.025 (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 61.00 60.00 62.00 61.00 61.00 61.00 36,509 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Water Supply 10.03M -3.99M -0.1736 -3.51 14.02M

MyCelx Technologies Corporation Contract Award (6252F)

11/07/2023 7:00am

UK Regulatory


Mycelx Technologies (LSE:MYX)
Historical Stock Chart


From Jun 2023 to Jun 2024

Click Here for more Mycelx Technologies Charts.

TIDMMYX TIDMMYXR

RNS Number : 6252F

MyCelx Technologies Corporation

11 July 2023

11 July 2023

MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)

Contract Award

MYCELX Technologies Corporation ("MYCELX" or the "Company"), the clean water and clean air technology company, is pleased to announce the award of a contract extension for wastewater treatment at a leading independent petrochemical facility in the Middle East.

This contract, together with the award announced on 3(rd) July 2023 for wastewater treatment in the Middle East, will generate revenue in aggregate in excess of $2 million in 2023 across the two contracts and helps underpin the current market forecast for the current year.

Connie Mixon, CEO, commented:

"Our technology and expertise continue to provide customers with effective solutions for treating complex process water. Maintaining the high level of performance that our customers require is extremely important to us and sets us apart from competitors."

For further information, please contact:

 
MYCELX Technologies Corporation 
 Connie Mixon, CEO                                   Tel: +1 888 306 6843 
 Kim Slayton, CFO 
Canaccord Genuity Limited (Nomad and Sole Broker) 
 Henry Fitzgerald-O'Connor                           Tel: +44 20 7523 8000 
 Gordon Hamilton 
Celicourt Communications (Financial PR) 
 Mark Antelme                                        Tel: +44 20 7770 6424 
 Jimmy Lea 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

STRNKDBKPBKKOOD

(END) Dow Jones Newswires

July 11, 2023 02:00 ET (06:00 GMT)

1 Year Mycelx Technologies Chart

1 Year Mycelx Technologies Chart

1 Month Mycelx Technologies Chart

1 Month Mycelx Technologies Chart